{
    "2021-04-01": [
        [
            {
                "time": "2021-08-15",
                "original_text": "Pfizer, Biotech vaccine shows strong results after 6 months",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Biotech",
                        "vaccine",
                        "strong results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-16",
                "original_text": "Abbott-Quidel Rapid COVID-19 Test Cleared by FDA",
                "features": {
                    "keywords": [
                        "Abbott-Quidel",
                        "Rapid",
                        "COVID-19",
                        "Test",
                        "Cleared",
                        "FDA"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-17",
                "original_text": "Abbott’s BinaxNOW COVID-19 Ag Self Test Cleared For Emergency Use In US",
                "features": {
                    "keywords": [
                        "Abbott",
                        "BinaxNOW",
                        "COVID-19",
                        "Self Test",
                        "Emergency Use",
                        "US"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "diagnostics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-18",
                "original_text": "U.S. okays Abbott's rapid COVID-19 test for at-home screenings in those without symptoms",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Abbott",
                        "rapid",
                        "COVID-19",
                        "test",
                        "at-home",
                        "screenings",
                        "without symptoms"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "diagnostics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-19",
                "original_text": "Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use",
                "features": {
                    "keywords": [
                        "Abbott",
                        "BinaxNOW™",
                        "Rapid Antigen",
                        "Self Test",
                        "FDA",
                        "Emergency Use Authorization",
                        "Asymptomatic",
                        "Over-the-Counter",
                        "Non-Prescription",
                        "Multi-Test Use"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "diagnostics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}